MAS Omni IMMUNE PRO Liquid Assayed Control Recall: Low PTH Recovery Risk
Microgenics recalls MAS Omni IMMUNE PRO Liquid Assayed Control (Lot OPRO29061A) due to low Parathyroid Hormone recovery risks in test results. Affected units sold worldwide in 2026.
Lower-risk recall
Vial-to-vial variability in MAS¿ Omni"IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, Lot OPRO29061A results in low Parathyroid Hormone (PTH) recovery, which may lead to a delay in reporting patient PTH results.
What happened, in plain English
Microgenics recalls a specific blood test control product because inconsistent results may delay accurate Parathyroid Hormone measurements. This could affect medical testing accuracy for patients using the product. Read more at govinfonow.com/recall/1764890-microgenics-corporation-recalls-mas-omni-immune-pro-liquid-assayed-integrated.
Source Summary by GovInfoNow · govinfonow.com/recall/1764890-microgenics-corporation-recalls-mas-omni-immune-pro-liquid-assayed-integrated · Published October 27, 2026 · Updated October 27, 2026 · FDA enforcement record: FDA #Z-0159-2027
Cite this page
“MAS Omni IMMUNE PRO Liquid Assayed Control Recall: Low PTH Recovery Risk.” GovInfoNow, updated October 27, 2026. https://govinfonow.com/recall/1764890-microgenics-corporation-recalls-mas-omni-immune-pro-liquid-assayed-integrated. Based on FDA recall #Z-0159-2027 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0159-2027%22&limit=1).
Why it’s dangerous
The control product has inconsistent results between vials, leading to low Parathyroid Hormone recovery. This may cause delays in reporting accurate patient test results.
Who’s affected
Patients using this blood test control product for medical testing may experience delayed Parathyroid Hormone results. Healthcare providers using the product in labs are most at risk.
How to tell if you have this one
Check for the product name 'MAS Omni IMMUNE PRO Liquid Assayed Control' with lot number OPRO29061A. The expiration date is June 30, 2029.
- Brand
Microgenics- Category
Medical device
What to do — step by step
Check Product Details
Verify the lot number on the product label is OPRO29061A.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 11 states.
FDA distribution: “Worldwide - US Nationwide distribution in the states of UT, MI, OK, NY, TX, CA, LA, SC, OH, MO, OR and the countries of KOR, BGD, THA, ZAF, DEU, VNM, BRA, NZL.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: California, Louisiana, Michigan, Missouri, New York, Ohio, Oklahoma, Oregon, South Carolina, Texas, Utah.
Recall timeline
FDA published this recall 2 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-0159-2027 (August 17, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0159-2027 to see it in context.
- Plain-language summary written by qwen3:4b on October 27, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.